# FAPI PET Imaging - An Exploratory Study

Source: https://onco.cc/trials/nct07705074/  
OnCo record `nct07705074` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial in pancreatic cancer, run by Martin Huellner, not yet recruiting.

## Summary

FAPI PET Imaging - An Exploratory Study is a phase 1/2, interventional study registered as NCT07705074 by Martin Huellner, with a registry enrolment figure of 770 participants, started 2026-08 and due to reach its primary completion in 2029-09. Interventions recorded: [18F]FAPI-74 PET/CT. Conditions listed: Thyroid Pathology; Head and Neck Cancer (H&N); Sinonasal Tract Tumor; Sarcoidosis; Thyroid Cancer; Breast Cancer; Hepatocellular Carcinoma (HCC); Gastric Cancer (GC); Pancreatic Cancer, Adult; Urothelial Carcinoma (UC); Multiple Myeloma or Plasmacytoma; Mesothelioma; Hepatic Fibrosis; Endometriosis (Diagnosis); Lung Fibrosis; Neck Node Metastasis; Prostate Cancer (CRPC). Primary outcome: Diagnostic Interpretability and Uptake Classification of [18F]FAPI-74 PET Imaging. Sites: Switzerland. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-24
- Also known as: FAPIPET
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT07705074
- Phase: 1/2
- Setting: FAPI PET Imaging - a Multicentric Exploratory Evaluation
- Sponsor: Martin Huellner
- Enrolled: 770

## Sources

- ClinicalTrials.gov NCT07705074: https://clinicaltrials.gov/study/NCT07705074

## Connected records

- cancers: [Metastatic pancreatic ductal adenocarcinoma](https://onco.cc/cancers/metastatic-pdac/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct07705074.json